DNA RNA and Cells

09 Jul 2020 Precision BioSciences Regains Rights to In Vivo Hepatitis B Virus Program
08 Jul 2020 Kiadis licenses previously undisclosed pre-clinical K-NK-cell programs to Sanofi, with total potential deal value of €875 million, plus royalties
07 Jul 2020 Celixir provides update on ongoing clinical programme with lead therapeutic candidate CLXR-001
07 Jul 2020 Johns Hopkins Reports Promising Clinical Data in COVID-19 ARDS Treated with Cellenkos' Cord Blood T-Regulatory Cells
07 Jul 2020 Cellectis Reports Clinical Hold Placed on MELANI-01 Study
06 Jul 2020 GenSight Biologics Reports Sustained Efficacy and Safety Among LHON Patients Three Years After LUMEVOQ® Treatment
03 Jul 2020 AffyImmune Therapeutics presents novel CAR T development programs at the annual meeting of the American Association of Cancer Research
02 Jul 2020 AltruBio moves forward with clinical development of Neihulizumab in Steroid-Refractory Acute Graft-versus-Host Disease after encouraging Phase 1a results
02 Jul 2020 Xenetic Biosciences, Inc. Provides Development Update for Its Personalized CAR T Platform Technology, XCART(TM)
01 Jul 2020 BioCardia Announces Activation of Pivotal Trial Studying CardiAMP Cell Therapy Trial to Treat Chronic Myocardial Ischemia
01 Jul 2020 Amniox Announces Initiation for First of Two Phase 3 Clinical Trials of Cryopreserved Umbilical Cord TTAX01 Allograft to Treat Complex Wagner Grade 3-4 Diabetic Foot Ulcers
30 Jun 2020 AOBiome Reports Successful Clinical Trials (Phase 2a in Adults and Phase 1b in Pediatrics) in Pruritus (Itch) Associated with Atopic Dermatitis
29 Jun 2020 SFA Therapeutics Announces FDA Approval To Begin IND Trial
29 Jun 2020 PTC Therapeutics Announces CHMP Recommendation of Translarna™ (ataluren) Label Update for Non-Ambulatory Patients with Duchenne Muscular Dystrophy
29 Jun 2020 Rocket Pharmaceuticals Announces FDA Clearance of IND for RP-L401 Gene Therapy for Infantile Malignant Osteopetrosis
28 Jun 2020 Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Casimersen (SRP-4045) for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 45
28 Jun 2020 Verve Therapeutics Presents New Data in Non-Human Primates Validating Gene Editing as a Treatment Approach for Coronary Heart Disease at the ISSCR 2020 Virtual Annual Meeting
26 Jun 2020 Artiva Biotherapeutics Launches with $78 Million Series A Financing to Advance NK Cell Therapies to Treat Cancer
26 Jun 2020 Seelos Therapeutics Announces Initiation of Preclinical Study of SLS-007 in Parkinson's Disease
26 Jun 2020 Highlight Therapeutics announces first patient dosed in Phase IIa study in liver metastasis
26 Jun 2020 Nurix Therapeutics Announces Formation of DeCART Therapeutics to Advance New CAR T Therapies Using Targeted Protein Modulation
25 Jun 2020 Acceleron Presents Topline Results of the PULSAR Phase 2 Trial of Sotatercept in Patients with Pulmonary Arterial Hypertension
25 Jun 2020 uniQure Announces License Agreement with CSL Behring to Commercialize Hemophilia B Gene Therapy
24 Jun 2020 Medigene enters Phase I clinical development with its TCR-T immunotherapy MDG1021 in hematological cancers
23 Jun 2020 Medigene’s PD1-41BB Switch Receptor Enhances TCR-T Cell Activity Towards Solid Tumors

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up